DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Arjo AB (publ)

OTCPK:ARRJ.F Stock Report

Market Cap: US$794.5m

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Arjo Past Earnings Performance

Past criteria checks 1/6

Arjo's earnings have been declining at an average annual rate of -12.8%, while the Medical Equipment industry saw earnings growing at 18.2% annually. Revenues have been growing at an average rate of 4.7% per year. Arjo's return on equity is 4.9%, and it has net margins of 3.5%.

Key information

-12.83%

Earnings growth rate

-12.83%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate4.67%
Return on equity4.95%
Net Margin3.52%
Next Earnings Update22 Oct 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Arjo makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ARRJ.F Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2610,9163843,636134
31 Mar 2610,8353513,629136
31 Dec 2511,0003343,674140
30 Sep 2511,1754383,722146
30 Jun 2511,2634303,764149
31 Mar 2511,3964573,796151
31 Dec 2411,2924983,747150
30 Sep 2411,1825053,698157
30 Jun 2411,2255133,700157
31 Mar 2411,1014993,669154
31 Dec 2310,9804803,625149
30 Sep 2310,7873943,587132
30 Jun 2310,5293993,493125
31 Mar 2310,2473983,397120
31 Dec 229,9794493,298115
30 Sep 229,7495443,228123
30 Jun 229,4776483,116114
31 Mar 229,2727333,027105
31 Dec 219,0707422,975100
30 Sep 219,0127272,94395
30 Jun 218,9086692,948103
31 Mar 218,9735942,974106
31 Dec 209,0785263,054114
30 Sep 209,1565103,085130
30 Jun 209,1674233,100130
31 Mar 209,1154083,137133
31 Dec 198,9764033,072139
30 Sep 198,8073413,062130
30 Jun 198,6343543,016132
31 Mar 198,4083462,919152
31 Dec 188,2172962,876141
30 Sep 187,9781312,906150
30 Jun 187,79232,832146
31 Mar 187,70042,836125
31 Dec 177,6881182,707134
30 Sep 177,7942662,635136
31 Dec 167,8084902,408133
31 Dec 158,1153072,614118

Quality Earnings: ARRJ.F has high quality earnings.

Growing Profit Margin: ARRJ.F's current net profit margins (3.5%) are lower than last year (3.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ARRJ.F's earnings have declined by 12.8% per year over the past 5 years.

Accelerating Growth: ARRJ.F's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ARRJ.F had negative earnings growth (-10.7%) over the past year, making it difficult to compare to the Medical Equipment industry average (15.6%).


Return on Equity

High ROE: ARRJ.F's Return on Equity (4.9%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/09 12:53
End of Day Share Price 2026/09/08 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Arjo AB (publ) is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Erik CasselDanske Bank

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide